Labcorp Holdings Inc. (LH) Current Ratio: 1.42
Is Labcorp Holdings Inc.’s current ratio high or low?
Labcorp Holdings Inc.'s current ratio of 1.42 is in line with its 5-year average of 1.52, around the middle of its 5-year range (1.17–1.92).
As of Sunday, June 14, 2026. 0.70% below its 12-month average of 1.43.
LH Current Ratio Chart
LH Average Current Ratio Chart
LH Current vs Average Current Ratio Chart
LH Current Ratio Metrics
CURRENT RATIO
1.42
CURRENT RATIO AVG TTM
1.43
CURRENT RATIO AVG 3Y
1.38
CURRENT RATIO AVG 5Y
1.52
CURRENT RATIO AVG 10Y
1.45
CURRENT RATIO AVG 15Y
1.41
CURRENT RATIO AVG 20Y
1.34
CURRENT VS TTM AVG
-0.70%
CURRENT VS 3Y AVG
+2.71%
CURRENT VS 5Y AVG
-6.48%
CURRENT VS 10Y AVG
-1.76%
CURRENT VS 15Y AVG
+0.58%
CURRENT VS 20Y AVG
+6.08%
LH Competitors' Current Ratio
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Labcorp Holdings Inc. (LH) | $21.83B | 1.42 | 1.43 | 1.38 | 1.52 |
| Mettler-Toledo International Inc. (MTD) | $22.86B | 1.14 | 1.08 | 1.10 | 1.13 |
| BioNTech SE (BNTX) | $22.90B | 7.54 | 7.50 | 7.96 | 6.49 |
| United Therapeutics Corporation (UTHR) | $23.17B | 6.60 | 5.92 | 6.53 | 6.74 |
| Waters Corporation (WAT) | $23.17B | 1.73 | 1.92 | 2.08 | 2.07 |
| Moderna, Inc. (MRNA) | $19.80B | 3.29 | 3.48 | 3.28 | 2.72 |
| Veeva Systems Inc. (VEEV) | $25.92B | 4.89 | 4.70 | 4.39 | 4.08 |
| Hologic, Inc. (HOLX) | $16.97B | 3.75 | 3.72 | 3.76 | 3.20 |
| DexCom, Inc. (DXCM) | $29.08B | 1.88 | 1.67 | 2.04 | 3.15 |
| Biogen Inc. (BIIB) | $29.53B | 2.68 | 2.02 | 2.25 | 2.11 |
Liquidity Analysis
Current Ratio
1.42
Quick Ratio
1.23
Labcorp Holdings Inc. Current Ratio Formula & Definition
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Labcorp Holdings Inc. Current Ratio FAQ
- What is the current ratio for Labcorp Holdings Inc. (LH)?
- The current ratio for LH stock is 1.42.
- Is Labcorp Holdings Inc.'s current ratio high or low?
- Labcorp Holdings Inc.'s current ratio of 1.42 is in line with its 5-year average of 1.52, around the middle of its 5-year range (1.17–1.92).
- What is the TTM average current ratio for Labcorp Holdings Inc. (LH)?
- The TTM average current ratio for LH stock is 1.43.
- What is the 3Y average current ratio for Labcorp Holdings Inc. (LH)?
- The 3Y average current ratio for LH stock is 1.38.
- What is the 5Y average current ratio for Labcorp Holdings Inc. (LH)?
- The 5Y average current ratio for LH stock is 1.52.
- What is the 10Y average current ratio for Labcorp Holdings Inc. (LH)?
- The 10Y average current ratio for LH stock is 1.45.
- What is the 15Y average current ratio for Labcorp Holdings Inc. (LH)?
- The 15Y average current ratio for LH stock is 1.41.
- What is the 20Y average current ratio for Labcorp Holdings Inc. (LH)?
- The 20Y average current ratio for LH stock is 1.34.
Labcorp Holdings Inc. Current Ratio History
| DATE | CURRENT RATIO |
|---|---|
| 2025-12-31 | 1.42 |
| 2024-12-31 | 1.44 |
| 2023-12-31 | 1.17 |
| 2022-12-31 | 1.50 |
| 2021-12-31 | 1.92 |
| 2020-12-31 | 1.66 |
| 2019-12-31 | 1.12 |
| 2018-12-31 | 1.51 |
| 2017-12-31 | 1.23 |
| 2016-12-31 | 1.36 |
| 2015-12-31 | 1.57 |
| 2014-12-31 | 1.73 |
| 2013-12-31 | 1.62 |
| 2012-12-31 | 1.15 |
| 2011-12-31 | 1.17 |
| 2010-12-31 | 1.02 |
| 2009-12-31 | 0.92 |
| 2008-12-31 | 1.89 |
| 2007-12-31 | 0.97 |
| 2006-12-31 | 0.95 |
| 2005-12-31 | 0.79 |
| 2004-12-31 | 2.46 |
| 2003-12-31 | 0.87 |
| 2002-12-31 | 2.64 |
| 2001-12-31 | 3.10 |
| 2000-12-31 | 1.64 |
| 1999-12-31 | 2.03 |
| 1998-12-31 | 2.06 |
| 1997-12-31 | 2.68 |
| 1996-12-31 | 2.85 |
Related Metrics
About Labcorp Holdings Inc.
Labcorp Holdings, Inc. offers vital diagnostic laboratory services, enabling medical professionals, healthcare facilities, pharmaceutical firms, scientific investigators, and patients to make well-informed and confident choices. The company commenced operations on April 16, 2024, and its main office is situated in Burlington, NC.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Adam H. Schechter